Nature Communications (May 2021)
Deep learning predicts cardiovascular disease risks from lung cancer screening low dose computed tomography
Abstract
Low dose computed tomography (LDCT) for lung cancer screening offers an opportunity for simultaneous CVD risk estimation in at-risk patients. Here, the authors develop a deep learning model to perform this task, showing human-level performance.